3653 results for «445»
3653 results
Andreas Grüntzig Ethica Award ceremony
15 May 2024 – From EuroPCR 2024
This session is the Andreas Grüntzig Ethica Award ceremony.
Cutting-edge abstracts on coronary and valvular interventions
04 Oct 2024 – From AICT-AsiaPCR 2024
Explore the latest research and advancements in coronary and valvular interventions through this session featuring selected abstracts from the AICT-AsiaPCR 2024 conference. Delve into topics ranging from the impact of radiation safety practices, innovative techniques for bifurcated left main interventions, and comparative analyses of intravascular lithotripsy...
DCB case studies: Balloon loss, stent recovery and severe in-stent restenosis
04 Oct 2024 – From AICT-AsiaPCR 2024
Explore this captivating session featuring a diverse array of challenging clinical cases from the AICT-AsiaPCR 2024 conference. Delve into scenarios where interventional cardiologists faced unexpected complications, such as balloon and stent loss, and learn how they navigated these complex situations. Discover insights on managing lesions of...
Optimising outcomes in treating multivessel disease - LIVE case
04 Oct 2024 – From AICT-AsiaPCR 2024
A 75-year-old male with hypertension, dyslipidemia and a lot of co-morbidities presented a positive echo stress test. The coronary angiography showed diffuse calcified disease on LAD, CX, OM1 and RCA. There is significant stenosis on ostial RCA, mid LAD, mid CX and OM1.
After physiology assessment...
Elixir Medical To Announce Late-Breaking Clinical Data at EuroPCR 2023 Session Featuring World’s First Transforming Coronary Artery Implant Designed to Restore Vessel Physiology and Function
09 May 2023
EuroPCR 2026: Elixir Medical's DynamX® bioadaptor demonstrates significantly lower event rates than drug-eluting stent in long-term follow-up, including reduction in cardiovascular death
19 May 2026
EuroPCR 2025: Late-breaking data demonstrate sustained significantly lower event rates with Elixir Medical’s DynamX® Bioadaptor over drug-eluting stent through three Years
21 May 2025
A randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons for treatment of calcified and refractory coronary lesions - The VICTORY trial
27 Oct 2025
Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.
Author
Positive 3-year results from FIRE Trial demonstrate Supraflex Cruz’s safety and efficacy in elderly heart attack patients
26 Sep 2025
Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT
03 Nov 2023
Elixir Medical’s DynamX Bioadaptor demonstrates significant improvement over contemporary drug-eluting stent in patients with acute coronary syndrome and complex lesion subsets after six months
28 Oct 2024
EuroPCR 2024: Late-breaking data demonstrate significant clinical advantage of Elixir Medical’s DynamX bioadaptor over standard-of-care drug-eluting stent at two years
14 May 2024
EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)
17 May 2023